Trending Now
Key Financial Highlights and Analysts’ Recommendations (COIN,FDX,FLNC,ALGN,CNC)
In a recent revelation by ADP, job creation in the U.S. witnessed a deceleration in August, falling short of expectations and hinting...
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a pioneer in biotechnology, has recently achieved a critical milestone in its fight against acute myeloid leukemia...
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a trailblazer in the development of Antibody Radiation Conjugates (ARCs) and targeted radiotherapy treatments, is at...
Popular News
Sarepta Therapeutics Inc. (NASDAQ: SRPT) Reports Preliminary Q3 2021 Results And...
Sarepta Therapeutics Inc. (NASDAQ: SRPT) has announced its preliminary Q3 2021 financial results. The company expects net product revenues of $166.9 million relative to...
MAKE IT MODERN
LATEST REVIEWS
AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) Announce Promising Survival Results Of Study Of...
AIM ImmunoTech Inc (NYSEAMERICAN:AIM) has announced that it has received a statistically significant promising pancreatic cancer survival results from its multi-year Early Access Program...
MAKE IT MODERN
PERFORMANCE TRAINING
Evogene Ltd’s (NASDAQ: EVGN) AgPlenus Ltd., Subsidy Has Announced That It Has Achieved Positive...
Evogene Ltd (NASDAQ: EVGN) subsidy, AgPlenus Ltd., recently announced positive results. The results were announced for a Proof of Concept (POC) testing of a...
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Announces Its Focus And Progress Across Its ATTR Amyloidosis Programs
When a team of distinguished scientific leaders came together in 2002, they did not know that their vision would forever transform people's lives. Their...
Mustang Bio Inc. (NASDAQ:MBIO) Receives Orphan Drug Designation For MB-207 in Treating XSCID patients
Mustang Bio Inc. (NASDAQ:MBIO) has been awarded Orphan Drug Designation for MB-207, its lentiviral gene therapy for treating patients with X-linked severe combined immunodeficiency...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Shows Readout Of Positive Results From RELIEF Phase...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) presented a readout of the positive results from the Phase 3 Clinical trial, RELIEF study, of TNX-102 SL...
Atara Biotherapeutics Inc. (NASDAQ:ATRA) Reports Phase 1a ATA188 Data With Progressive Multiple Sclerosis Patients...
Atara Biotherapeutics Inc. (NASDAQ:ATRA) has announced the presentation of results from the first part of its current Phase 1 ATA188 study in treating progressive...
MAKE IT MODERN
POPULAR
